Advances in LBP Manufacturing: Microbiotica and Biose Industrie Prepare for Clinical Studies

Microbiotica, a biotechnology firm focused on developing precision microbiome medicines known as live biotherapeutic products (LBPs), is preparing for clinical …

Continue ›››

Biostate AI Launches RNA Sequencing and Data Analysis Services

Biostate AI, a startup focused on scalable biodata solutions, has launched two new service products aimed at advancing multiomic data …

Continue ›››

Light-weight Microscope Captures Large-scale Brain Activity in Freely Moving Mice

Researchers at Rockefeller University have developed a new lightweight microscope capable of capturing large-scale brain activity in mice while they …

Continue ›››

Myricx Bio Secures £90m Series A Funding to Progress NMTi-ADC Therapeutics into Clinical Trials

Myricx Bio, a UK-based biotechnology company specializing in novel antibody-drug conjugates (ADCs), has raised £90 million ($114 million) in a …

Continue ›››

FDA Approves Signet Therapeutics' IND Application for sigx1094 in Diffuse Gastric Cancer

Signet Therapeutics, a biotechnology company specializing in targeted cancer therapy, has received FDA approval for its Investigational New Drug (IND) …

Continue ›››

OMNY Health Partners with QuantHealth and ArisGlobal to Enhance AI-Driven Healthcare Solutions

OMNY Health, a healthcare ecosystem specializing in compliant cross-industry data sharing, has launched a platform designed to support AI-driven health …

Continue ›››

Aptamer Group Partners with AstraZeneca to Explore Optimer Vehicles for siRNA Delivery

Aptamer Group, a developer of novel Optimer® binders for the life sciences industry, has entered into an agreement with AstraZeneca …

Continue ›››

Waypoint Bio Secures $14.5 Million to Advance Drug Discovery with Innovative In Vivo Spatial Pooled Screening Technology

Waypoint Bio, a biotechnology company focused on developing novel cell therapies for solid tumors, has raised $14.5 million in seed …

Continue ›››

A Booming Anti-Obesity Drug Discovery Landscape at a Glance (With Challenges)

In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite. This research …

Continue ›››

New DNA-Editing Technique Offers Potential for Advanced Genome Engineering

Researchers at the Arc Institute in California have identified a novel DNA-editing mechanism in bacteria, dubbed the “bridge editing” system, …

Continue ›››

Formation Bio Secures $372 Million Series D Funding for AI-Driven Drug Development

Formation Bio, an AI-native pharmaceutical company, has raised $372 million in Series D financing, led by a16z and Sanofi. Additional …

Continue ›››

Evaxion Biotech Receives Positive Feedback on Patent Application for Personalized Vaccine Targets

Evaxion Biotech A/S, a clinical-stage TechBio company known for its AI-Immunology™ powered vaccines, has received favorable feedback regarding its recent …

Continue ›››